van der Laan BFAM - Search Results

1

Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer.

de Vries J, Bras L, Sidorenkov G, Festen S, Steenbakkers RJHM, Langendijk JA, Witjes MJH, van der Laan BFAM, de Bock GH, Halmos GB. de Vries J, et al. Among authors: van der laan bfam. Oral Oncol. 2020 Dec;111:105020. doi: 10.1016/j.oraloncology.2020.105020. Epub 2020 Oct 9. Oral Oncol. 2020. PMID: 33045628 Free article.

2

Shoulder and neck morbidity in quality of life after surgery for head and neck cancer.

van Wilgen CP, Dijkstra PU, van der Laan BF, Plukker JT, Roodenburg JL. van Wilgen CP, et al. Head Neck. 2004 Oct;26(10):839-44. doi: 10.1002/hed.20052. Head Neck. 2004. PMID: 15390203

3

Critical weight loss in head and neck cancer--prevalence and risk factors at diagnosis: an explorative study.

Jager-Wittenaar H, Dijkstra PU, Vissink A, van der Laan BF, van Oort RP, Roodenburg JL. Jager-Wittenaar H, et al. Support Care Cancer. 2007 Sep;15(9):1045-50. doi: 10.1007/s00520-006-0212-9. Epub 2007 Feb 3. Support Care Cancer. 2007. PMID: 17277925 Free article.

4

Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.

Gibcus JH, Menkema L, Mastik MF, Hermsen MA, de Bock GH, van Velthuysen ML, Takes RP, Kok K, Alvarez Marcos CA, van der Laan BF, van den Brekel MW, Langendijk JA, Kluin PM, van der Wal JE, Schuuring E. Gibcus JH, et al. Clin Cancer Res. 2007 Nov 1;13(21):6257-66. doi: 10.1158/1078-0432.CCR-07-1247. Clin Cancer Res. 2007. PMID: 17975136

5

FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.

Krabbe CA, Pruim J, van der Laan BF, Rödiger LA, Roodenburg JL. Krabbe CA, et al. Oral Oncol. 2009 Mar;45(3):234-40. doi: 10.1016/j.oraloncology.2008.05.024. Epub 2008 Aug 19. Oral Oncol. 2009. PMID: 18715818

6

Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.

Schrijvers ML, van der Laan BF, de Bock GH, Pattje WJ, Mastik MF, Menkema L, Langendijk JA, Kluin PM, Schuuring E, van der Wal JE. Schrijvers ML, et al. Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):161-9. doi: 10.1016/j.ijrobp.2008.05.025. Int J Radiat Oncol Biol Phys. 2008. PMID: 18722267

7

Visualization of small glottic laryngeal cancer using methyl-labeled 11C-methionine positron emission tomography.

Wedman J, Pruim J, Langendijk JA, van der Laan BF. Wedman J, et al. Oral Oncol. 2009 Aug;45(8):703-5. doi: 10.1016/j.oraloncology.2008.10.017. Epub 2009 Jan 14. Oral Oncol. 2009. PMID: 19147393

8

Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.

Schrijvers ML, van Riel EL, Langendijk JA, Dikkers FG, Schuuring E, van der Wal JE, van der Laan BF. Schrijvers ML, et al. Head Neck. 2009 Jun;31(6):759-64. doi: 10.1002/hed.21027. Head Neck. 2009. PMID: 19260127

9

Groningen dilatation tracheoscope in treatment of moderate subglottic and tracheal stenosis.

Halmos GB, van der Laan BF, Dikkers FG. Halmos GB, et al. Ann Otol Rhinol Laryngol. 2009 May;118(5):329-35. doi: 10.1177/000348940911800503. Ann Otol Rhinol Laryngol. 2009. PMID: 19548381

10

[18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.

Been LB, Hoekstra HJ, Suurmeijer AJ, Jager PL, van der Laan BF, Elsinga PH. Been LB, et al. Oral Oncol. 2009 Dec;45(12):e211-5. doi: 10.1016/j.oraloncology.2009.07.008. Epub 2009 Aug 18. Oral Oncol. 2009. PMID: 19692292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters